A jury in an Illinois state court found on Monday that British pharmaceutical giant GSK’s (NYSE:GSK) discontinued heartburn medication, Zantac was not responsible for causing colorectal cancer ...

The In re Zantac (Ranitidine) Litigation appeal provides the First State's high court a prime opportunity to clarify Delaware law on those two issues and remind trial judges that in most instances ...

Zion Williamson accused of rape, ongoing abuse in lawsuit against Pelicans star Williamson's attorneys deny allegations, calling them 'false and reckless' Scooby Axson Jeff Zillgitt.

GSK topped the Stoxx Europe 600 index after the pharmaceutical company agreed to pay up to $2.2 billion to settle thousands of U.S. lawsuits over claims its discontinued heartburn medicine Zantac ...

GSK to pay $70 million to settle whistleblower lawsuit Pfizer and Sanofi also settling Zantac cases Boehringer Ingelheim faces trial, denies wrongdoing Oct 9 (Reuters) - GSK (GSK.L), opens new tab ...

GSK has agreed to pay $2.2 billion to settle most of the pending lawsuits that claimed a discontinued version of the Zantac heartburn medication caused cancer.

The lawsuit aims to seek damages for the investors who felt the company was not being honest about the drug’s potential cancer risk that they had known about prior, the Ohio AG’s office said.

Pharmaceutical companies have agreed to pay Hawaii $700 million to settle its lawsuit over the efficacy and safety of the blood thinner Plavix, the state attorney general's office announced Friday.

The Food and Drug Administration asked in 2020 that all Zantac products, which relied on a heartburn drug developed by GSK, be taken off the market. The current Zantac 360 uses a different active ...

Family of Tyrone Mason, who died in Raleigh car crash, files federal lawsuit against NC State Trooper Garrett Macario over his handling of accident and aftermath.

Zantac went on sale in the UK in 1981. ... British drugs firm GSK has been accused of burying a report said to prove a link between its medication Zantac and cancer, a new lawsuit has claimed.

GSK has agreed to pay up to $2.2 billion to settle most lawsuits in US state courts claiming that a discontinued version of the heartburn drug Zantac caused cancer, the company announced on Wednesday.